Management ChangeMay 4, 2026, 07:00 AM
Tenax Therapeutics Appoints Timothy Healey as Chief Commercial Officer
AI Summary
Tenax Therapeutics, a Phase 3 pharmaceutical company, announced the appointment of Timothy Healey, MBA, as its new Chief Commercial Officer (CCO), effective immediately. Mr. Healey brings extensive experience in leading successful drug launches and developing innovative commercialization models. In his new role, he will be responsible for overseeing Tenax's global commercial strategy and preparing TNX-103 for its commercial launch.
Key Highlights
- Tenax Therapeutics appointed Timothy Healey as Chief Commercial Officer (CCO).
- Mr. Healey will oversee the company's global commercial strategy.
- He will prepare Tenax and TNX-103 for commercial launch success.
- He previously served as CCO at Eversana Life Science Services.
- Mr. Healey also held senior commercial roles at Lantheus, AbbVie, and AMAG Pharmaceuticals.
- He has a proven track record of successful drug launches and commercialization models.
Price Impact
More from TENX